We are live on
!
Find out more
EC
EcoR1 Capital Portfolio holdings
AUM
$2.34B
1-Year Est. Return
204.53%
This Fund
S&P 500
This Quarter
Est. Return
+17.84%
1 Year Est. Return
+204.53%
3 Year Est. Return
+306.25%
5 Year Est. Return
+490.45%
10 Year Est. Return
+14,115.48%
AUM
$3.94B
AUM Growth
+$87M
(+2.3%)
Cap. Flow
-$18.2M
Cap. Flow
% of AUM
-0.46%
Top 10 Holdings %
Top 10 Hldgs %
61.38%
Holding
66
New
15
Increased
8
Reduced
4
Closed
9
Top Buys
| 1 |
Sarepta Therapeutics
SRPT
|
+$133M |
| 2 |
CRISPR Therapeutics
CRSP
|
+$99.5M |
| 3 |
Crinetics Pharmaceuticals
CRNX
|
+$83.8M |
| 4 |
MORF
Morphic Holding, Inc. Common Stock
MORF
|
+$72.8M |
| 5 |
ADAP
Adaptimmune Therapeutics
ADAP
|
+$33.1M |
Top Sells
| 1 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
+$435M |
| 2 |
argenx
ARGX
|
+$115M |
| 3 |
Edgewise Therapeutics
EWTX
|
+$35.6M |
| 4 |
Spyre Therapeutics
SYRE
|
+$19.1M |
| 5 |
Revolution Medicines
RVMD
|
+$3.8M |
Sector Composition
| 1 | Healthcare | 99.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
APLS
1
DELISTED
Apellis Pharmaceuticals
APLS
| $668M | 16.95% |
11,357,425
+184,357
| +2% | +$11.8M |
|
2
Prothena Corp
PRTA
$449M
| $287M | 7.29% |
11,584,280
| – | – |
|
3
Arvinas
ARVN
$531M
| $278M | 7.05% |
6,726,491
| – | – |
|
|
4
Sarepta Therapeutics
SRPT
$1.83B
| $249M | 6.31% |
1,919,835
+1,086,928
| +130% | +$133M |
|
|
5
Crinetics Pharmaceuticals
CRNX
$8.88B
| $195M | 4.94% |
4,155,375
+2,142,858
| +106% | +$83.8M |
|
|
LKFT
6
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.94B
| $185M | 4.71% |
5,756,268
| – | – |
|
7
AnaptysBio
ANAB
$1.69B
| $169M | 4.3% |
7,521,024
| – | – |
|
8
Zymeworks
ZYME
$1.79B
| $141M | 3.59% |
13,437,473
| – | – |
|
9
Kura Oncology
KURA
$1B
| $124M | 3.14% |
5,806,871
| – | – |
|
10
Jazz Pharmaceuticals
JAZZ
$14.9B
| $122M | 3.1% |
1,013,952
| – | – |
|
11
Xencor
XNCR
$1.11B
| $118M | 3% |
5,330,416
+47,900
| +0.9% | +$1.03M |
|
12
Acadia Pharmaceuticals
ACAD
$4.44B
| $111M | 2.81% |
5,991,479
| – | – |
|
13
Tango Therapeutics
TNGX
$4.95B
| $106M | 2.69% |
13,330,736
| – | – |
|
14
Immunome
IMNM
$2.59B
| $95.7M | 2.43% |
3,879,415
| – | – |
|
|
15
CRISPR Therapeutics
CRSP
$5.03B
| $94.7M | 2.4% |
+1,389,276
| New | +$99.5M |
|
|
MRSN
16
DELISTED
Mersana Therapeutics
MRSN
| $86.8M | 2.2% |
774,588
| – | – |
|
|
MORF
17
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $83.9M | 2.13% |
2,384,384
+2,173,122
| +1,029% | +$72.8M |
|
18
Nuvation Bio
NUVB
$2.03B
| $69.9M | 1.78% |
19,209,643
| – | – |
|
19
Neurogene
NGNE
$786M
| $64.7M | 1.64% |
1,271,342
| – | – |
|
|
CNTA
20
DELISTED
Centessa Pharmaceuticals
CNTA
| $63.5M | 1.61% |
5,618,779
| – | – |
|
21
Oric Pharmaceuticals
ORIC
$1.16B
| $47M | 1.19% |
3,418,068
| – | – |
|
|
ADAP
22
DELISTED
Adaptimmune Therapeutics
ADAP
| $43.3M | 1.1% |
+27,404,070
| New | +$33.1M |
|
23
TScan Therapeutics
TCRX
$60.6M
| $39.7M | 1.01% |
5,000,000
| – | – |
|
24
Voyager Therapeutics
VYGR
$192M
| $36.5M | 0.93% |
3,917,546
+66,039
| +2% | +$558K |
|
|
THRD
25
DELISTED
Third Harmonic Bio
THRD
| $30M | 0.76% |
3,182,444
| – | – |
|
Similar funds
G
MC
BAM
CC
HFM
NO
ST
MFAM